BioCryst Pharmaceuticals, Inc. (BCRX)
BioCryst Pharmaceuticals, Inc. (BCRX)
$3.59 USD
0.01 (-0.28%)
Updated Jul 16 2:29pm
Add BCRX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
BCRX Daily Price Range
BCRX 52-Week Price Range
BCRX News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 15, 2019
Best & Worst Performing Small Cap Stocks for July 15, 2019
Best & Worst Performing Mid Cap Stocks for July 15, 2019
Best & Worst Performing Large Cap Stocks for July 15, 2019
Best & Worst Performing Mega Cap Stocks for July 15, 2019
View All Top StoriesBioCryst Pharmaceuticals, Inc. (BCRX) Company Bio
Biocryst Pharmaceuticals designs, optimizes and develops novel small molecule drugs that block key enzymes involved in rare diseases. The company was founded in 1986 and is based in Durham, North Carolina.
BCRX Stock Chart More Charts
BCRX Price/Volume Stats
| Current price | $3.59 |
| Prev. close | $3.60 |
| Day low | $3.56 |
| Day high | $3.63 |
| 50-day MA | $4.46 |
| 200-day MA | $7.23 |
| 52-week high | $9.95 |
| 52-week low | $2.80 |
| Volume | 205,870 |
| Avg. volume | 1,493,726 |
| Dividend yield | N/A |
| Market Cap | 396.02M |
BCRX Returns
| 1-mo | 5.90% |
| 3-mo | -53.32% |
| 6-mo | -61.11% |
| 1-year | -42.10% |
| 3-year | 21.28% |
| 5-year | -66.48% |
| YTD | -55.51% |
| 2018 | 64.36% |
| 2017 | -22.43% |
| 2016 | -38.66% |
| 2015 | -15.13% |
| 2014 | 60.00% |
Loading social stream, please wait...